Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (161-170 of 392) with videos related to

Pageof 40
Sort By:
The Journal of Antimicrobial Chemotherapy|August 24, 2018
MIC-based dose adjustment: facts and fables-authors' responseJohan W Mouton, Anouk E Muller, Rafael Canton, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2019
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessusHannelore I Bax, Corné P de Vogel, Johan W Mouton, et al.
Journal of Clinical Microbiology|September 15, 2004
Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S. mitis and other streptococciChris Neeleman, Corné H W Klaassen, Debbie M Klomberg, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1996
Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategyA A Vinks, J W Mouton, D J Touw, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 1, 1997
Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patientsNicole H. M. Renders, Alex van Belkum, Shelley E. Overbeek, et al.
Medical Mycology|January 31, 2009
Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosisJ W Mouton, D T A te Dorsthorst, J F G M Meis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
Plasma and epithelial lining fluid pharmacokinetics of ceftolozane and tazobactam alone and in combination in miceM J Melchers, E Mavridou, S Seyedmousavi, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosisAlexander A Vinks, Jan G Den Hollander, Shelley E Overbeek, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Method for measuring postantifungal effect in Aspergillus speciesRoxana G Vitale, Johan W Mouton, Javier Afeltra, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus speciesJavier Afeltra, Jacques F G M Meis, Roxana G Vitale, et al.
Pageof 40

Showing results (161-170 of 392) with videos related to

Sort By:
Pageof 40
The Journal of Antimicrobial Chemotherapy|August 24, 2018
MIC-based dose adjustment: facts and fables-authors' responseJohan W Mouton, Anouk E Muller, Rafael Canton, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2019
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessusHannelore I Bax, Corné P de Vogel, Johan W Mouton, et al.
Journal of Clinical Microbiology|September 15, 2004
Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S. mitis and other streptococciChris Neeleman, Corné H W Klaassen, Debbie M Klomberg, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1996
Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategyA A Vinks, J W Mouton, D J Touw, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 1, 1997
Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patientsNicole H. M. Renders, Alex van Belkum, Shelley E. Overbeek, et al.
Medical Mycology|January 31, 2009
Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosisJ W Mouton, D T A te Dorsthorst, J F G M Meis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
Plasma and epithelial lining fluid pharmacokinetics of ceftolozane and tazobactam alone and in combination in miceM J Melchers, E Mavridou, S Seyedmousavi, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosisAlexander A Vinks, Jan G Den Hollander, Shelley E Overbeek, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Method for measuring postantifungal effect in Aspergillus speciesRoxana G Vitale, Johan W Mouton, Javier Afeltra, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus speciesJavier Afeltra, Jacques F G M Meis, Roxana G Vitale, et al.
Pageof 40